[Carcinogenesis of hepatitis C virus core protein using recombinant adenoassociated virus technology].
Li
Hua
H
Department of Surgery, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
Chen
Gui-hua
GH
Wang
Xin-lu
XL
Han
Fu-xia
FX
Pan
Chen-en
CE
D000818:Animals; D002471:Cell Transformation, Neoplastic; D003001:Cloning, Molecular; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D018936:Hepatitis C Antigens / Q000633:toxicity; D008114:Liver Neoplasms, Experimental / Q000473:pathology / Q000821:virology*; D008297:Male; D009858:Oncogenic Viruses / Q000472:pathogenicity; D012333:RNA, Messenger / Q000633:toxicity; D051381:Rats; D017207:Rats, Sprague-Dawley; D011993:Recombinant Fusion Proteins / Q000633:toxicity; D014758:Viral Core Proteins / Q000633:toxicity*; D014771:Virion / Q000472:pathogenicity
D018936:Hepatitis C Antigens; D012333:RNA, Messenger; D011993:Recombinant Fusion Proteins; D014758:Viral Core Proteins; C069130:nucleocapsid protein, Hepatitis C virus